Literature DB >> 11354597

Moderator variables of executive functioning in schizophrenia: meta-analytic findings.

M Johnson-Selfridge1, C Zalewski.   

Abstract

The literature regarding executive functioning in schizophrenia was examined to determine effect size differences between schizophrenic, normal control, and psychiatric groups. Effect sizes (n = 176) from 71 studies were cumulated across measures including the Wisconsin Card Sorting Test (WCST), Halstead Category Test (HCT), verbal/design fluency, Trail Making B (TMB), and the Stroop Color-Word Test. Schizophrenic groups were impaired relative to controls (delta = -1.45). Schizophrenic groups also performed 0.40 standard deviations lower than psychiatric groups. Within the schizophrenic versus normal control comparisons, the effect size based on complex measures, such as the WCST/HCT (delta = -1.42), was similar to that based on less complex measures, such as TMB and the Stroop (delta = -1.58). Chlorpromazine equivalents and illness duration were not significantly correlated with effect sizes (p > 0.05). Effect sizes and number of hospitalizations (p < 0.05) were related. Effect sizes and Brief Psychiatric Rating Scale (BPRS) were not significantly correlated. Negative and positive symptoms were significantly correlated (p < 0.05). The results as they apply to research and clinical practice are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11354597     DOI: 10.1093/oxfordjournals.schbul.a006876

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  26 in total

1.  The feasibility of cognitive adaptation training for outpatients with schizophrenia in integrated treatment.

Authors:  Jens Peter Hansen; Birte Østergaard; Merete Nordentoft; Lise Hounsgaard
Journal:  Community Ment Health J       Date:  2012-10-12

2.  Familial resemblance for executive functions in families of schizophrenic and bipolar patients.

Authors:  Andrei Szöke; Franck Schürhoff; Jean-Louis Golmard; Caroline Alter; Isabelle Roy; Alexandre Méary; Bruno Etain; Frank Bellivier; Marion Leboyer
Journal:  Psychiatry Res       Date:  2006-10-02       Impact factor: 3.222

3.  The Processing-Speed Impairment in Psychosis Is More Than Just Accelerated Aging.

Authors:  Samuel R Mathias; Emma E M Knowles; Jennifer Barrett; Olivia Leach; Sebastiano Buccheri; Tamara Beetham; John Blangero; Russell A Poldrack; David C Glahn
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

4.  Factors in sensory processing of prosody in schizotypal personality disorder: an fMRI experiment.

Authors:  Chandlee C Dickey; Istvan A Morocz; Daniel Minney; Margaret A Niznikiewicz; Martina M Voglmaier; Lawrence P Panych; Usman Khan; Rayna Zacks; Douglas P Terry; Martha E Shenton; Robert W McCarley
Journal:  Schizophr Res       Date:  2010-04-01       Impact factor: 4.939

5.  Directed forgetting in schizophrenia: prefrontal memory and inhibition deficits.

Authors:  Ulrich Müller; Markus Ullsperger; Eva Hammerstein; Stefan Sachweh; Thomas Becker
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-22       Impact factor: 5.270

6.  Computerized neurocognitive test performance in schizophrenia: a lifespan analysis.

Authors:  Farzin Irani; Colleen M Brensinger; Jan Richard; Monica E Calkins; Paul J Moberg; Waren Bilker; Raquel E Gur; Ruben C Gur
Journal:  Am J Geriatr Psychiatry       Date:  2012-01       Impact factor: 4.105

7.  The latent structure of psychiatric symptoms across mental disorders as measured with the PANSS and BPRS-18.

Authors:  Richard A Van Dorn; Sarah L Desmarais; Kevin J Grimm; Stephen J Tueller; Kiersten L Johnson; Brian G Sellers; Marvin S Swartz
Journal:  Psychiatry Res       Date:  2016-08-09       Impact factor: 3.222

8.  Prosodic abnormalities in schizotypal personality disorder.

Authors:  Chandlee C Dickey; Mai-Anh T Vu; Martina M Voglmaier; Margaret A Niznikiewicz; Robert W McCarley; Lawrence P Panych
Journal:  Schizophr Res       Date:  2012-10-12       Impact factor: 4.939

9.  Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

Authors:  S Kristian Hill; John A Sweeney; Robert M Hamer; Richard S E Keefe; Diana O Perkins; Hongbin Gu; Joseph P McEvoy; Jeffrey A Lieberman
Journal:  J Int Neuropsychol Soc       Date:  2008-03       Impact factor: 2.892

10.  IQ-related fMRI differences during cognitive set shifting.

Authors:  Steven Graham; Jiaying Jiang; Victoria Manning; Ayna Baladi Nejad; Koh Zhisheng; Shan R Salleh; Xavier Golay; Yeh Ing Berne; Peter J McKenna
Journal:  Cereb Cortex       Date:  2009-07-01       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.